MIRM Mirum Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1759425 · EDGAR
- Bought, last 12 months
- $9.00M 1 purchases by 1 insiders
- Sold, last 12 months
- $42.20M 42 sales by 7 insiders
- Filings on record
- 240 since 2021-07-07, latest 2026-09-15 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Peetz Christopher | CEO, Dir | — | $16.29M |
| GREY MICHAEL G | Dir | — | $11.10M |
| Heron Patrick J | Dir | $9.00M | — |
| Howe Jolanda | SVP, Gbl Ctrl | — | $5.55M |
| BJERKHOLT ERIC | CFO | — | $3.56M |
| Radovich Peter | Pres AND COO | — | $2.32M |
| Ramasastry Saira | Dir | — | $1.92M |
| Quan Joanne | Chief MEDICAL Off | — | $1.46M |
| Cardon Lon | Dir | — | — |
| Fischer Laurent | Dir | — | — |
Transactions 261
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-06-15 | 2023-06-13 | MIRM | SANDELL SCOTT D | 10% | J - Other | $0.00 | -1.99M | 163 | -100% | $0 |
| MI | 2023-06-15 | 2023-06-13 | MIRM | Walker Paul Edward | 10% | J - Other | $0.00 | -2.00M | 0 | -100% | $0 |
| 2023-06-15 | 2023-06-13 | MIRM | New Enterprise Associates 16, L.P. | 10% | J - Other | $0.00 | -2.00M | 2.19M | -48% | $0 | |
| MI | 2023-06-15 | 2023-06-13 | MIRM | Florence Anthony A. Jr. | 10% | J - Other | $0.00 | -1.99M | 0 | -100% | $0 |
| 2023-06-15 | 2023-06-13 | MIRM | Florence Anthony A. Jr. | 10% | J - Other | $0.00 | +384 | 384 | New | $0 | |
| 2023-06-15 | 2023-06-13 | MIRM | Chang Carmen | 10% | J - Other | $0.00 | +135 | 135 | New | $0 | |
| MI | 2023-06-15 | 2023-06-13 | MIRM | Chang Carmen | 10% | J - Other | $0.00 | -2.00M | 0 | -100% | $0 |
| MI | 2023-06-15 | 2023-06-13 | MIRM | BASKETT FOREST | 10% | J - Other | $0.00 | -2.00M | 0 | -100% | $0 |
| MI | 2023-06-15 | 2023-06-13 | MIRM | Behbahani Ali | 10% | J - Other | $0.00 | -2.00M | 30.0K | -99% | $0 |
| M | 2023-06-15 | 2023-06-13 | MIRM | NEA Partners 16, L.P. | 10% | J - Other | $0.00 | 0 | 30.0K | New | $0 |
| I | 2023-06-15 | 2023-06-13 | MIRM | NEA Partners 16, L.P. | 10% | J - Other | $0.00 | -2.00M | 2.19M | -48% | $0 |
| D | 2023-06-09 | 2023-06-08 | MIRM | GREY MICHAEL G | Dir | S - Sale+OE | $29.00 | -14.6K | 0 | -100% | -$423.6K |
| D | 2023-06-09 | 2023-06-08 | MIRM | GREY MICHAEL G | Dir | M - OptEx | $2.94 | +14.6K | 14.6K | New | +$42.9K |
| 2023-05-19 | 2023-05-10 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $16.92 | +684 | 106.8K | +0.6% | +$11.6K | |
| 2023-05-19 | 2023-05-10 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $16.92 | +1,256 | 120.8K | +1% | +$21.3K | |
| 2023-05-19 | 2023-05-10 | MIRM | Radovich Peter | COO | A - Grant | $16.92 | +968 | 39.1K | +3% | +$16.4K | |
| 2023-05-19 | 2023-05-10 | MIRM | Vig Pamela | Head of Research, Development | A - Grant | $16.92 | +684 | 32.2K | +2% | +$11.6K | |
| D | 2023-05-04 | 2023-05-03 | MIRM | GREY MICHAEL G | Dir | S - Sale+OE | $28.00 | -14.6K | 0 | -100% | -$409.0K |
| D | 2023-05-04 | 2023-05-03 | MIRM | GREY MICHAEL G | Dir | M - OptEx | $2.94 | +14.6K | 14.6K | New | +$42.9K |
| D | 2023-02-02 | 2023-01-31 | MIRM | Vig Pamela | Head of Research, Development | A - Grant | $0.00 | +9,625 | 31.5K | +44% | $0 |
| D | 2023-02-02 | 2023-01-31 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +50.0K | 119.6K | +72% | $0 |
| D | 2023-02-02 | 2023-01-31 | MIRM | Radovich Peter | COO | A - Grant | $0.00 | +14.4K | 38.1K | +61% | $0 |
| D | 2023-02-02 | 2023-01-31 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $0.00 | +9,625 | 106.2K | +10% | $0 |
| MI | 2022-11-15 | 2022-11-11+ | MIRM | O'Donnell Niall | Dir | S - Sale | $19.85 | -300.0K | 1.71M | -15% | -$5.96M |
| 2022-11-14 | 2022-11-10 | MIRM | Radovich Peter | COO | A - Grant | $17.05 | +292 | 23.7K | +1% | +$4,979 | |
| 2022-11-14 | 2022-11-10 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $17.05 | +82 | 96.5K | +0.1% | +$1,398 | |
| 2022-11-14 | 2022-11-10 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $17.05 | +49 | 69.6K | +0.1% | +$835.45 | |
| 2022-11-14 | 2022-11-10 | MIRM | Clements Ian | CFO | A - Grant | $17.05 | +325 | 30.0K | +1% | +$5,541 | |
| 2022-11-14 | 2022-11-10 | MIRM | Vig Pamela | Head of Research, Development | A - Grant | $17.05 | +660 | 21.9K | +3% | +$11.3K | |
| MI | 2022-06-08 | 2022-06-06 | MIRM | Deerfield Private Design Fund IV, L.P. | 10%, * Possible Member of 10% Group | S - Sale | $25.01 | -38.5K | 1.71M | -2% | -$962.3K |
| 2022-05-12 | 2022-05-10 | MIRM | Vig Pamela | Head of Research, Development | A - Grant | $13.57 | +807 | 21.2K | +4% | +$11.0K | |
| 2022-05-12 | 2022-05-10 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $13.57 | +1,500 | 69.5K | +2% | +$20.4K | |
| 2022-05-12 | 2022-05-10 | MIRM | Radovich Peter | COO | A - Grant | $13.57 | +1,169 | 23.4K | +5% | +$15.9K | |
| 2022-05-12 | 2022-05-10 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $13.57 | +1,454 | 96.5K | +2% | +$19.7K | |
| 2022-05-12 | 2022-05-10 | MIRM | Clements Ian | CFO | A - Grant | $13.57 | +1,125 | 29.7K | +4% | +$15.3K | |
| D | 2022-01-07 | 2022-01-06 | MIRM | Vig Pamela | CSO | A - Grant | $0.00 | +10.0K | 20.4K | +96% | $0 |
| D | 2022-01-07 | 2022-01-06 | MIRM | Clements Ian | CFO | A - Grant | $0.00 | +10.0K | 28.6K | +54% | $0 |
| D | 2022-01-07 | 2022-01-06 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $0.00 | +10.0K | 95.0K | +12% | $0 |
| D | 2022-01-07 | 2022-01-06 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 68.0K | +143% | $0 |
| D | 2022-01-07 | 2022-01-06 | MIRM | Radovich Peter | COO | A - Grant | $0.00 | +10.0K | 22.2K | +82% | $0 |
| M | 2021-11-29 | 2021-11-24+ | MIRM | Clements Ian | CFO | P - Purchase | $14.14 | +1,450 | 18.6K | +8% | +$20.5K |
| 2021-11-29 | 2021-11-24 | MIRM | Peetz Christopher | Pres, CEO, Dir | P - Purchase | $14.40 | +7,000 | 28.0K | +33% | +$100.8K | |
| 2021-11-15 | 2021-11-10 | MIRM | Radovich Peter | COO | A - Grant | $13.52 | +958 | 12.2K | +8% | +$13.0K | |
| 2021-11-15 | 2021-11-10 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $13.52 | +753 | 85.0K | +0.9% | +$10.2K | |
| 2021-11-15 | 2021-11-10 | MIRM | Vig Pamela | CSO | A - Grant | $13.52 | +768 | 10.4K | +8% | +$10.4K | |
| 2021-11-15 | 2021-11-10 | MIRM | Clements Ian | CFO | A - Grant | $13.52 | +458 | 17.1K | +3% | +$6,192 | |
| 2021-11-15 | 2021-11-10 | MIRM | Tucker Edwin Jonathan | Chief Medical Off | A - Grant | $13.52 | +70 | 45.8K | +0.2% | +$946.40 | |
| 2021-10-01 | 2021-09-29 | MIRM | Peetz Christopher | Pres, CEO, Dir | A - Grant | $0.00 | +21.9K | 24.7K | +775% | $0 | |
| 2021-10-01 | 2021-10-01 | MIRM | Peetz Christopher | Pres, CEO, Dir | S - Sale | $19.26 | -3,672 | 21.0K | -15% | -$70.7K | |
| 2021-10-01 | 2021-09-29 | MIRM | Vig Pamela | CSO | A - Grant | $0.00 | +8,125 | 11.0K | +280% | $0 | |
| 2021-10-01 | 2021-10-01 | MIRM | Vig Pamela | CSO | S - Sale | $19.26 | -1,364 | 9,667 | -12% | -$26.3K | |
| 2021-10-01 | 2021-10-01 | MIRM | Longpre Lara | Chief Development Off | S - Sale | $19.26 | -961 | 84.2K | -1% | -$18.5K | |
| 2021-10-01 | 2021-09-29 | MIRM | Longpre Lara | Chief Development Off | A - Grant | $0.00 | +8,125 | 85.2K | +11% | $0 | |
| 2021-10-01 | 2021-09-29 | MIRM | Clements Ian | CFO | A - Grant | $0.00 | +9,375 | 18.2K | +106% | $0 | |
| 2021-10-01 | 2021-10-01 | MIRM | Clements Ian | CFO | S - Sale | $19.26 | -1,574 | 16.7K | -9% | -$30.3K | |
| 2021-10-01 | 2021-10-01 | MIRM | Radovich Peter | COO | S - Sale | $19.26 | -1,364 | 11.3K | -11% | -$26.3K | |
| 2021-10-01 | 2021-09-29 | MIRM | Radovich Peter | COO | A - Grant | $0.00 | +8,125 | 12.6K | +180% | $0 | |
| 2021-10-01 | 2021-09-29 | MIRM | Tucker Edwin Jonathan | Chief Medical Off | A - Grant | $0.00 | +8,125 | 47.1K | +21% | $0 | |
| 2021-10-01 | 2021-10-01 | MIRM | Tucker Edwin Jonathan | Chief Medical Off | S - Sale | $19.26 | -1,364 | 45.8K | -3% | -$26.3K | |
| I | 2021-07-13 | 2021-07-09 | MIRM | Deerfield Private Design Fund IV, L.P. | 10%, * Possible Member of 10% Group | S - Sale | $15.81 | -99.3K | 0 | -100% | -$1.57M |
| MI | 2021-07-07 | 2021-07-02+ | MIRM | Deerfield Mgmt HIF, L.P. | 10%, * Possible Member of 10% Group | S - Sale | $16.29 | -66.7K | 106.2K | -39% | -$1.09M |
Purchase Sale Sale after option exercise All abbreviations